We identified ECM protein decorin as similarly and significantly altered in CSF of three different AD mouse models exhibiting Aβ pathology and in preclinical AD subjects having abnormal-amyloid/normal-tau CSF levels (a + t −). This evidence concerns the gene DCN and Alzheimer disease.